Literature DB >> 23686634

Intradural extramedullary benign spinal lesions radiosurgery. Medium- to long-term results from a single institution experience.

Marcello Marchetti1, Elena De Martin, Ida Milanesi, Laura Fariselli.   

Abstract

BACKGROUND: Surgery represents the first-choice treatment for spinal intradural tumours. On the other hand, whether it is most appropriate in the setting of recurrences, residual or multiple lesions remains an open question. Moreover, some patients are less than ideal candidates for surgery. In this study we report about our own radiosurgery experience in the treatment of benign intradural extramedullary tumours of the spine.
METHODS: In our study we analyzed the outcomes for 18 patients (21 lesions) treated for benign intradural extramedullary lesions, with a minimum follow-up period of 32 months. The lesions included 11 meningiomas, 9 schwannomas and 1 neurofibroma.
RESULTS: The mean follow-up was 43 months (32-73 months). The median tumour volume was 2 cc (0.2-17.7 cc). Eleven lesions underwent single-fraction treatment (mean prescribed dose ranging from 10 to 13 Gy). The others received a multisession radiosurgery treatment (4-6 fractions) with a mean prescription dose ranging from 18.5 to 25 Gy. The maximum dose to the spinal cord ranged from 9.2 to 26 Gy. During the follow-up period, none of the lesions showed radiological evidence of progression. Neurological status was preserved or improved and no permanent sequelae were observed. Significant and durable pain relief was observed.
CONCLUSIONS: Although surgical excision remains the primary treatment option for most intradural tumours, radiosurgery offers a real alternative therapeutic modality, especially in case of recurrent and residual lesions or when surgery is contraindicated.

Entities:  

Mesh:

Year:  2013        PMID: 23686634     DOI: 10.1007/s00701-013-1756-3

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  Predictors of complications and readmission following spinal stereotactic radiosurgery.

Authors:  Daniel Lubelski; Joseph E Tanenbaum; Taylor E Purvis; Thomas T Bomberger; Courtney Rory Goodwin; Ilya Laufer; Daniel M Sciubba
Journal:  CNS Oncol       Date:  2017-07-18

Review 2.  Review of stereotactic radiosurgery for intradural spine tumors.

Authors:  Taylor E Purvis; C Rory Goodwin; Daniel Lubelski; Ilya Laufer; Daniel M Sciubba
Journal:  CNS Oncol       Date:  2017-04

Review 3.  Stereotactic body radiotherapy for benign spinal tumors: Meningiomas, schwannomas, and neurofibromas.

Authors:  Lindsay Hwang; Christian C Okoye; Ravi B Patel; Arjun Sahgal; Matthew Foote; Kristin J Redmond; Christoph Hofstetter; Rajiv Saigal; Mahmud Mossa-Basha; William Yuh; Nina A Mayr; Samuel T Chao; Eric L Chang; Simon S Lo
Journal:  J Radiosurg SBRT       Date:  2019

Review 4.  Recent advances in intradural spinal tumors.

Authors:  Muhammad M Abd-El-Barr; Kevin T Huang; Ziev B Moses; J Bryan Iorgulescu; John H Chi
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

Review 5.  The role of stereotactic radiosurgery in the treatment of intramedullary spinal cord neoplasms: a systematic literature review.

Authors:  Silvia Hernández-Durán; Simon Hanft; Ricardo J Komotar; Glen R Manzano
Journal:  Neurosurg Rev       Date:  2015-07-30       Impact factor: 3.042

6.  Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT).

Authors:  Ivan Veronese; Elena De Martin; Anna Stefania Martinotti; Maria Luisa Fumagalli; Cristina Vite; Irene Redaelli; Tiziana Malatesta; Pietro Mancosu; Giancarlo Beltramo; Laura Fariselli; Marie Claire Cantone
Journal:  Radiat Oncol       Date:  2015-06-13       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.